Other Vaccines - Botswana

Botswana

Highlights

The Other Vaccines market in Botswana is expected to witness significant growth in the coming years.
It is projected that the revenue in this market will reach US$4.55m units in 2024.
Furthermore, an annual growth rate of 10.80% (CAGR 2024-2029) is anticipated, which will result in a market volume of US$7.60m units by 2029.
In global comparison, it is worth noting that United States is expected to generate the highest revenue in the Other Vaccines market, with an estimated value of US$24.73bn units in 2024.
Botswana is experiencing a growing demand for other vaccines as the government focuses on expanding its healthcare infrastructure.

Key regions:

Market definitionIn-Scope/Out-of-scopeMarket structureReportsMethodology

Botswana, a landlocked country in Southern Africa, has been experiencing a steady growth in its healthcare sector over the past few years. As a result, the Other Vaccines market in Botswana has also been developing with the increasing awareness of the importance of vaccination among the population.

Customer preferences: The population of Botswana has shown a growing interest in preventive healthcare measures, including vaccinations. The government has been actively promoting the importance of vaccinations, and this has led to an increase in demand for Other Vaccines. Additionally, the country has a high prevalence of HIV/AIDS, which has resulted in a higher demand for vaccines that protect against related infections.

Trends in the market: The Other Vaccines market in Botswana has been growing due to the increasing demand for preventive healthcare measures. There has been a significant increase in the number of healthcare facilities in the country, which has led to greater access to vaccines for the population. The government has been actively promoting the importance of vaccination, and this has led to an increase in the number of people seeking vaccination services.

Local special circumstances: Botswana has a high prevalence of HIV/AIDS, which has resulted in a higher demand for vaccines that protect against related infections. Additionally, the country has a high incidence of malaria, which has led to an increase in demand for vaccines that protect against the disease. The government has been actively promoting the importance of vaccination, and this has led to an increase in demand for Other Vaccines.

Underlying macroeconomic factors: Botswana has been experiencing steady economic growth over the past few years, which has led to an increase in the country's healthcare budget. The government has been investing in the healthcare sector, which has led to an increase in the number of healthcare facilities in the country. Additionally, the country has a stable political environment, which has encouraged foreign investment in the healthcare sector. These underlying macroeconomic factors have contributed to the growth of the Other Vaccines market in Botswana.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.